Lysophosphatidylcholine as a ligand for immunoregulation

Biochemical Pharmacology

Volumn 64, Issue 2, 2002, Pages 161-167

  Kabarowski, Janusz H S ^a   Xu, Yan ^b   Witte, Owen N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Immune regulation; Inflammation; Lysophosphatidylcholine; Oxidized low density lipoprotein; Phospholipase A2; Systemic autoimmune disease

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIGAND; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2;

ANTIGEN PRESENTATION; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELLULAR IMMUNITY; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE FUNCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ARTERIOSCLEROSIS; AUTOIMMUNITY; CELL CYCLE PROTEINS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNITY; LIGANDS; LYSOPHOSPHATIDYLCHOLINES; RECEPTORS, G-PROTEIN-COUPLED; T-LYMPHOCYTES;

EID: 0037099201     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01179-6     Document Type: Note

References (51)

1. Lysophospholipid receptors
2. Lysophospholipids - Receptor revelations
3. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue
4. Atherosclerosis
5. Lipoprotein(a) oxidation and autoantibodies: A new path in atherothrombosis
6. Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies
7. Cytokine dysregulation induced by apoptotic cells is a shared characteristic of murine lupus
8. Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
9. 2-GPI) in systemic lupus erythematosus
10. 2 pathway for the liberation of arachidonic acid
11. 2 enzymes in eicosanoid generation
12. Oxidized lipoproteins and atherosclerosis
13. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells
14. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells
15. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis
16. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes
17. 3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages
18. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism
19. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A
20. Immunology. The push-me pull-you of T cell activation
21. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4
22. 2/M
23. Direct genetic demonstration of Gα13 coupling to the orphan G protein-coupled receptor G2A leading to Rho-A-dependent actin rearrangement
24. G2A is an oncogenic G protein-coupled receptor
25. Mice lacking the orphan G protein-coupled receptor, G2A, develop a late-onset autoimmune syndrome
26. Isolation of three novel human genes encoding G protein-coupled receptors
27. Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14
28. Identification of a putative G protein-coupled receptor induced during activation-induced apoptosis of T cells
29. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
30. Identification of a molecular target of psychosine and its role in globoid cell formation
31. Albumin restores lysophosphatidylcholine-induced inhibition of vasodilation in rat aorta
32. Lysophosphatidic acids produced by lysophospholipase D in mammalian serum and body fluid
33. 13C]docosahexaenoic acid in two lipid forms to blood cells
34. Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain
35. Atherosclerosis-related markers in systemic lupus erythematosus patients: The role of humoral immunity in enhanced atherogenesis
36. Genetics of systemic lupus erythematosus. Clinical implications
37. 2 in signal transduction through protein kinase C
38. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity
39. Toll receptors in innate immunity
40. The induction of tolerance by dendritic cells that have captured apoptotic cells
41. Oxidative stress as a mediator of apoptosis
42. Death receptors: Signaling and modulation
43. 2-glycoprotein I-dependent manner
44. Apoptosis and autoimmunity
45. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition
46. 2 and C-reactive protein in the removal of injured cells
47. Involvement of protein kinase C-independent mechanisms in endothelial ICAM-1 up-regulation by lysophosphatidylcholine
48. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells
49. Oxidized-LDL and atherosclerosis. Role of LOX-1
50. Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase
51. Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A